Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential mFOLFIRI and mFOLFOX7 in advanced gastric cancer
ChiCTR-TRC-08000167Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2008
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fluorouracil, folinic acid, irinotecan and oxaliplatin in gastric adenocarcinoma and gastroesophageal junction adenocarcinoma (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Progression-free survival. Started Feb 2008; status: completed.
02
Drugs
fluorouracilfolinic acidirinotecanoxaliplatin
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on ChiCTR-TRC-08000167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000167.